Non-alcoholic fatty liver disease and hematologic manifestations (Review)

被引:6
|
作者
Padureanu, Vlad [1 ]
Dop, Dalia [2 ]
Dragoescu, Alice Nicoleta [3 ]
Padureanu, Rodica [4 ]
Musetescu, Anca Emanuela [5 ]
Nedelcu, Laurentiu [6 ]
机构
[1] Univ Med & Pharm Craiova, Dept Internal Med, Craiova 200349, Romania
[2] Univ Med & Pharm Craiova, Dept Pediat, Craiova 200349, Romania
[3] Univ Med & Pharm Craiova, Dept Anesthesiol & Intens Care, Craiova 200349, Romania
[4] Emergency Clin Cty Hosp Craiova, Dept Internal Med, 1 Tabaci St, Craiova 200642, Romania
[5] Univ Med & Pharm Craiova, Dept Rheumatol, 2-4 Petru Rares St, Craiova 200349, Romania
[6] Transylvania Univ Brasov, Fac Med, Dept Internal Med, Brasov 500019, Romania
关键词
non-alcoholic fatty liver; steatosis; ferritin levels; iron deposits; INSULIN-RESISTANCE; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; IRON OVERLOAD; FIBROSIS; MORTALITY; IMPACT; NAFLD; STEATOHEPATITIS; EPIDEMIOLOGY;
D O I
10.3892/etm.2021.10790
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is a multisystem disease, and it is associated with numerous extra-hepatic manifestations or additional co-occurring diseases. The aim of the present review was the identification and management of the hematologic manifestations of NAFLD. One of the triggers is considered to be iron abnormalities. Increased ferritin levels, hepatic iron deposits and iron overload are associated with NAFLD. The iron overload degree and severity are associated with the level of liver fibrosis and with the risk for hepatocellular carcinoma. Excess iron deposits refers to the dysmetabolic iron overload syndrome (DIOS) and it is characterized by steatosis associated with moderate tissue iron deposition and increased levels of serum ferritin, while the serum transferrin saturation was normal. Further prospective studies are necessary to determine whether NAFLD has an independent risk for hematologic symptoms, besides the known risk factors. Future studies are also needed in order to assess the increasing impact of NAFLD on the micro- and macro-vascular complications of this systemic disease.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Non-alcoholic fatty liver disease (NAFLD)
    Rau, Monika
    Weiss, Johannes
    Geier, Andreas
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1051 - +
  • [2] Epidemiology of Non-Alcoholic Fatty Liver Disease
    Bellentani, Stefano
    Scaglioni, Federica
    Marino, Mariano
    Bedogni, Giorgio
    DIGESTIVE DISEASES, 2010, 28 (01) : 155 - 161
  • [3] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [4] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    BMC MEDICINE, 2017, 15
  • [5] Comparing the performance of Fibrosis-4 and Non-Alcoholic Fatty Liver Disease Fibrosis Score with transient elastography scores of people with non-alcoholic fatty liver disease
    Cox, Ben
    Trasolini, Roberto
    Gaits, Ciaran
    Yoshida, Eric M.
    Marquez, Vladimir
    CANADIAN LIVER JOURNAL, 2021, 4 (03): : 275 - 282
  • [6] The Natural Course of Non-Alcoholic Fatty Liver Disease
    Bertot, Luis Calzadilla
    Adams, Leon Anton
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
  • [7] Non-alcoholic fatty liver disease:An expanded review
    Mark Benedict
    Xuchen Zhang
    World Journal of Hepatology, 2017, (16) : 715 - 732
  • [8] A Comprehensive Review on Non-Alcoholic Fatty Liver Disease
    Sahu, Prerna
    Chhabra, Pratyaksh
    Mehendale, Ashok M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [9] Pathology of non-alcoholic fatty liver disease
    Bedossa, Pierre
    LIVER INTERNATIONAL, 2017, 37 : 85 - 89
  • [10] Pediatric Non-Alcoholic Fatty Liver Disease
    Bush, Haley
    Golabi, Pegah
    Younossi, Zobair M.
    CHILDREN-BASEL, 2017, 4 (06):